KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40 | -9.1% | 4,215 | -14.1% | 0.00% | – |
| Q2 2023 | $44 | -54.6% | 4,906 | -60.5% | 0.00% | – |
| Q1 2023 | $97 | +115.6% | 12,413 | +88.9% | 0.00% | – |
| Q4 2022 | $45 | -99.9% | 6,572 | +148.1% | 0.00% | – |
| Q3 2022 | $38,000 | +100.0% | 2,649 | +34.5% | 0.00% | – |
| Q2 2022 | $19,000 | -64.8% | 1,970 | -45.8% | 0.00% | – |
| Q1 2022 | $54,000 | -93.0% | 3,638 | -93.7% | 0.00% | – |
| Q4 2021 | $766,000 | +323.2% | 57,972 | +457.2% | 0.00% | – |
| Q3 2021 | $181,000 | +48.4% | 10,404 | +105.2% | 0.00% | – |
| Q2 2021 | $122,000 | -85.7% | 5,069 | -84.8% | 0.00% | – |
| Q1 2021 | $854,000 | +228.5% | 33,283 | +143.3% | 0.00% | – |
| Q4 2020 | $260,000 | +40.5% | 13,680 | -6.7% | 0.00% | – |
| Q3 2020 | $185,000 | +9.5% | 14,658 | +4.7% | 0.00% | – |
| Q2 2020 | $169,000 | +106.1% | 14,001 | +31.1% | 0.00% | – |
| Q1 2020 | $82,000 | -81.5% | 10,679 | -57.1% | 0.00% | – |
| Q4 2019 | $444,000 | +112.4% | 24,896 | +38.1% | 0.00% | – |
| Q3 2019 | $209,000 | -59.0% | 18,034 | -21.6% | 0.00% | – |
| Q2 2019 | $510,000 | -45.2% | 23,007 | -29.2% | 0.00% | -100.0% |
| Q1 2019 | $930,000 | -25.0% | 32,489 | -48.2% | 0.00% | 0.0% |
| Q4 2018 | $1,240,000 | +61900.0% | 62,778 | +88319.7% | 0.00% | – |
| Q3 2018 | $2,000 | -84.6% | 71 | -94.7% | 0.00% | – |
| Q4 2017 | $13,000 | – | 1,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
| TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
| TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
| Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
| Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
| GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
| DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
| Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |